Your browser doesn't support javascript.
loading
Cognitive profiles of patients with mild cognitive impairment due to Alzheimer's versus Parkinson's disease defined using a base rate approach: Implications for neuropsychological assessments.
Ophey, Anja; Wolfsgruber, Steffen; Roeske, Sandra; Polcher, Alexandra; Spottke, Annika; Frölich, Lutz; Hüll, Michael; Jessen, Frank; Kornhuber, Johannes; Maier, Wolfgang; Peters, Oliver; Ramirez, Alfredo; Wiltfang, Jens; Liepelt-Scarfone, Inga; Becker, Sara; Berg, Daniela; Schulz, Jörg B; Reetz, Kathrin; Wojtala, Jennifer; Kassubek, Jan; Storch, Alexander; Balzer-Geldsetzer, Monika; Hilker-Roggendorf, Rüdiger; Witt, Karsten; Mollenhauer, Brit; Trenkwalder, Claudia; Wittchen, Hans-Ullrich; Riedel, Oliver; Dodel, Richard; Wagner, Michael; Kalbe, Elke.
Afiliação
  • Ophey A; Department of Medical Psychology Neuropsychology & Gender Studies; Center for Neuropsychological Diagnostics and Intervention (CeNDI) Faculty of Medicine and University Hospital Cologne, University of Cologne Cologne Germany.
  • Wolfsgruber S; Department of Neurodegenerative Diseases and Gerontopsychiatry University Hospital of Bonn University of Bonn Bonn Germany.
  • Roeske S; German Center for Neurodegenerative Diseases (DZNE) Bonn Germany.
  • Polcher A; Department of Neurodegenerative Diseases and Gerontopsychiatry University Hospital of Bonn University of Bonn Bonn Germany.
  • Spottke A; German Center for Neurodegenerative Diseases (DZNE) Bonn Germany.
  • Frölich L; Department of Neurodegenerative Diseases and Gerontopsychiatry University Hospital of Bonn University of Bonn Bonn Germany.
  • Hüll M; German Center for Neurodegenerative Diseases (DZNE) Bonn Germany.
  • Jessen F; German Center for Neurodegenerative Diseases (DZNE) Bonn Germany.
  • Kornhuber J; Department of Neurology University Hospital of Bonn University of Bonn Bonn Germany.
  • Maier W; Department of Geriatric Psychiatry Central Institute of Mental Health Medical Faculty Mannheim University of Heidelberg Heidelberg Germany.
  • Peters O; Emmendingen Center for Psychiatry and Department of Psychiatry and Psychotherapy University of Freiburg Emmendingen Germany.
  • Ramirez A; Department of Psychiatry and Psychotherapy Faculty of Medicine and University Hospital Cologne University of Cologne Cologne Germany.
  • Wiltfang J; Department of Psychiatry and Psychotherapy University Erlangen Erlangen Germany.
  • Liepelt-Scarfone I; Department of Psychiatry University Hospital of Bonn University of Bonn Bonn Germany.
  • Becker S; Department of Psychiatry Charité - Universitätsmedizin Berlin Berlin Germany.
  • Berg D; Department of Neurodegenerative Diseases and Gerontopsychiatry University Hospital of Bonn University of Bonn Bonn Germany.
  • Schulz JB; German Center for Neurodegenerative Diseases (DZNE) Bonn Germany.
  • Reetz K; Division of Neurogenetics and Molecular Psychiatry Department of Psychiatry Faculty of Medicine and University Hospital Cologne University of Cologne Cologne Germany.
  • Wojtala J; Clinic for Psychiatry and Psychotherapy University Medical Center Göttingen Göttingen Germany.
  • Kassubek J; German Center for Neurodegenerative Diseases (DZNE) Göttingen Germany.
  • Storch A; Hertie Institute for Clinical Brain Research Department of Neurodegenerative Diseases Tübingen Germany.
  • Balzer-Geldsetzer M; German Center for Neurodegenerative Diseases (DZNE) Tübingen Germany.
  • Hilker-Roggendorf R; IB-Hochschule für Gesundheit und Soziales Stuttgart Germany.
  • Witt K; Hertie Institute for Clinical Brain Research Department of Neurodegenerative Diseases Tübingen Germany.
  • Mollenhauer B; German Center for Neurodegenerative Diseases (DZNE) Tübingen Germany.
  • Trenkwalder C; Hertie Institute for Clinical Brain Research Department of Neurodegenerative Diseases Tübingen Germany.
  • Wittchen HU; Department of Neurology Christian-Albrechts-University of Kiel Kiel Germany.
  • Riedel O; Department of Neurology RWTH Aachen University Aachen Germany.
  • Dodel R; JARA-BRAIN Institute Molecular Neuroscience and Neuroimaging Forschungszentrum Jülich GmbH and RWTH Aachen University Aachen Germany.
  • Wagner M; Department of Neurology RWTH Aachen University Aachen Germany.
  • Kalbe E; JARA-BRAIN Institute Molecular Neuroscience and Neuroimaging Forschungszentrum Jülich GmbH and RWTH Aachen University Aachen Germany.
Alzheimers Dement (Amst) ; 13(1): e12223, 2021.
Article em En | MEDLINE | ID: mdl-34541284
ABSTRACT

INTRODUCTION:

Large studies on cognitive profiles of patients with mild cognitive impairment (MCI) due to Alzheimer's disease (AD-MCI) compared to Parkinson's disease (PD-MCI) are rare.

METHODS:

Data from two multicenter cohort studies in AD and PD were merged using a unified base rate approach for the MCI diagnosis. Cognitive profiles were compared using scores derived from the Consortium to Establish a Registry for Alzheimer's Disease battery.

RESULTS:

Patients with AD-MCI showed lower standardized scores on all memory test scores and a language test. Patients with PD-MCI showed lower standardized scores in a set-shifting measure as an executive task. A cross-validated logistic regression with test scores as predictors was able to classify 72% of patients correctly to AD-MCI versus PD-MCI.

DISCUSSION:

The applied test battery successfully discriminated between AD-MCI and PD-MCI. Neuropsychological test batteries in clinical practice should always include a broad spectrum of cognitive domains to capture any cognitive changes.
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Clinical_trials / Observational_studies / Prognostic_studies / Risk_factors_studies Idioma: En Ano de publicação: 2021 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Clinical_trials / Observational_studies / Prognostic_studies / Risk_factors_studies Idioma: En Ano de publicação: 2021 Tipo de documento: Article